Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
1 clinical trials · Condition
◉ Watch Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
| Record | Firm | Date |
|---|---|---|
| Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) (NCT03769467) | Atara Biotherapeutics | 2019-02-19 |
Track Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) automatically
Every clearance here is in the API, with alerts when new ones post.